Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study
Diabetes 67, 17101719
How did we determine the value-based price
Everything from enrollment to dose adjustments to nutrition guidance happens online
In this study, however, one-third of the involved population remained with the starting dose of 3 mg despite the recommendation reported in the summary of product characteristics and only 16% reached the maintenance dose of 14 mg [28]
I was having a significant problem with my bowels (nausea mostly) and stomach aches, and day long headaches
US$ 20.65
US$ 20.47
US$ 21.00
